Expired European patentEurope
Phagemide for screening antibodies
EP 1065271 B1 · Applicant: Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts
Overview
The published document from the EPO: abstract, claims, description and drawings. Open it full size
Read the whole patent
Listed from its EPO record in Patent Yard's archive of European patents past their term. Its claims, description and drawings are in the EPO PDF and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 6, 1992 and granted March 25, 2009. A European patent lasts at most 20 years from filing, so its term ended July 6, 2012.
- A supplementary protection certificate, which can extend a medicine or crop-protection patent, adds at most five and a half years, so even that would have ended by January 6, 2018.
- We check European rights only. A US or other national patent in its family could still be in force: check its family on Espacenet or Google Patents.
FiledJuly 6, 1992
PublishedJanuary 3, 2001
GrantedMarch 25, 2009
Term endedJuly 6, 2012
Application numberEP 00118282
Classification (CPC)C07K16/00 +2 more
Timeline
Timeline From EPO dates
Sources & verification
Official EPO records
Everything on this page comes from the EPO record linked above. EPO data used under CC BY 4.0.